What drives the rising cost of diabetes in urban China?
In 44,994 urban Chinese patients, mean annual diabetes-related medical costs rose from $1,293 (2014) to $2,093 (2019); hospitalization multiplied cost 2.23× and cardiovascular/kidney complications added ~65%/54%.
Source
Trends in economic burden of type 2 diabetes in China: Based on longitudinal claim data
Study at a glance
- Design
- Cohort — Longitudinal urban Chinese health-insurance claims 2014–2019 for people diagnosed with diabetes before January 2015; regression of DM cost on hospitalization and complications.
- N
- N=44994 · 44,994 patients (47% men; mean age 65.3); 89% UEBMI.
- Population
- Urban patients with diabetes in one eastern Chinese city, identified from the official health-management system.
- Outcome
- Annual diabetes-related direct medical cost (DM cost) and effects of hospitalization and six complication groups.
Structured fields used in claim comparison tables when every cited study has a complete layer.
What they did
Pulled 2014–2019 claims for everyone diagnosed with diabetes before 2015 in one eastern city, classified six ICD-10 complication groups, described stratified DM costs, and used clustered multiple linear regression (exponentiated β as cost multipliers).
What they found
Complications prevalence rose from 58.9% (2014) to 91.9% (2019). Cost AAGR was 10.12%. Hospitalized patients’ 2019 mean cost was $4,524 vs $1,172 without admission. Cost scaled with complication count (1.83× to 7.53× vs none). Cardiovascular (+65%) and nephropathy (+54%) were the priciest types.
The limits
What it doesn't show
One city and insurance claims miss informal care and undiagnosed diabetes; observational multipliers are not causal proof that preventing one complication saves exactly 54–65%; coding intensity may rise over time.
Key terms
- DM cost
- Diabetes-related direct medical cost from claims, including complication-related care.
- UEBMI / URRBMI
- Urban employee vs urban-rural resident basic medical insurance schemes covering this cohort.
- Hospitalization multiplier
- Average annual DM cost 2.23 times higher with vs without inpatient care.
- Complication count
- Number of six ICD-10 complication groups; more groups meant steeply higher cost.
- AAGR
- Average annual growth rate of mean DM cost (10.12% here).
Flashcards
Research intelligence for this paper
See its role on concept claims, tensions it is part of, placement history, and related discoveries.
Quiz yourself
Analytic n was about:
Common questions
How many patients?
44,994 people with diabetes.
Cost change 2014–2019?
From 1,292.72 to 2,092.87 USD per year on average.
Hospitalization effect?
2.23 times the DM cost of non-hospitalized patients.
Costliest complications?
Cardiovascular (+65%) and nephropathy (+54%).
More on Diabetes